Index of Veterinary Drugs

Functional Classes

Glossary

Cattle

Benzylpenicillin/Procaine benzylpenicillin

Tissue

MRL

Year of Adoption

Note

Kidney

50 µg/kg

1999

None

Tissue

Kidney

MRL

50 µg/kg

Year of Adoption

1999

Note

None

Liver

50 µg/kg

1999

None

Tissue

Liver

MRL

50 µg/kg

Year of Adoption

1999

Note

None

Milk

4 µg/l

1999

None

Tissue

Milk

MRL

4 µg/l

Year of Adoption

1999

Note

None

Muscle

50 µg/kg

1999

None

Tissue

Muscle

MRL

50 µg/kg

Year of Adoption

1999

Note

None

Showing 1 to 4 of 4 entries

Ceftiofur

Tissue

MRL

Year of Adoption

Note

Fat

2000 µg/kg

1999

None

Tissue

Fat

MRL

2000 µg/kg

Year of Adoption

1999

Note

None

Kidney

6000 µg/kg

1999

None

Tissue

Kidney

MRL

6000 µg/kg

Year of Adoption

1999

Note

None

Liver

2000 µg/kg

1999

None

Tissue

Liver

MRL

2000 µg/kg

Year of Adoption

1999

Note

None

Milk

100 µg/l

1999

None

Tissue

Milk

MRL

100 µg/l

Year of Adoption

1999

Note

None

Muscle

1000 µg/kg

1999

None

Tissue

Muscle

MRL

1000 µg/kg

Year of Adoption

1999

Note

None

Showing 1 to 5 of 5 entries

Chlortetracycline/Oxytetracycline/Tetracycline

Tissue

MRL

Year of Adoption

Note

Kidney

1200 µg/kg

2003

None

Tissue

Kidney

MRL

1200 µg/kg

Year of Adoption

2003

Note

None

Liver

600 µg/kg

2003

None

Tissue

Liver

MRL

600 µg/kg

Year of Adoption

2003

Note

None

Milk

100 µg/l

2003

None

Tissue

Milk

MRL

100 µg/l

Year of Adoption

2003

Note

None

Muscle

200 µg/kg

2003

None

Tissue

Muscle

MRL

200 µg/kg

Year of Adoption

2003

Note

None

Showing 1 to 4 of 4 entries

Clenbuterol

Tissue

MRL

Year of Adoption

Note

Fat

0.2 µg/kg

2003

Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.

Tissue

Fat

MRL

0.2 µg/kg

Year of Adoption

2003

Note

Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.

Kidney

0.6 µg/kg

2003

Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.

Tissue

Kidney

MRL

0.6 µg/kg

Year of Adoption

2003

Note

Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.

Liver

0.6 µg/kg

2003

Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.

Tissue

Liver

MRL

0.6 µg/kg

Year of Adoption

2003

Note

Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.

Milk

0.05 µg/l

2003

Tissue

Milk

MRL

0.05 µg/l

Year of Adoption

2003

Note

Muscle

0.2 µg/kg

2003

Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.

Tissue

Muscle

MRL

0.2 µg/kg

Year of Adoption

2003

Note

Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.

Showing 1 to 5 of 5 entries

Closantel

Tissue

MRL

Year of Adoption

Note

Fat

3000 µg/kg

1993

None

Tissue

Fat

MRL

3000 µg/kg

Year of Adoption

1993

Note

None

Kidney

3000 µg/kg

1993

None

Tissue

Kidney

MRL

3000 µg/kg

Year of Adoption

1993

Note

None

Liver

1000 µg/kg

1993

None

Tissue

Liver

MRL

1000 µg/kg

Year of Adoption

1993

Note

None

Muscle

1000 µg/kg

1993

None

Tissue

Muscle

MRL

1000 µg/kg

Year of Adoption

1993

Note

None

Showing 1 to 4 of 4 entries

Cyfluthrin

Tissue

MRL

Year of Adoption

Note

Fat

200 µg/kg

2003

None

Tissue

Fat

MRL

200 µg/kg

Year of Adoption

2003

Note

None

Kidney

20 µg/kg

2003

None

Tissue

Kidney

MRL

20 µg/kg

Year of Adoption

2003

Note

None

Liver

20 µg/kg

2003

None

Tissue

Liver

MRL

20 µg/kg

Year of Adoption

2003

Note

None

Milk

40 µg/l

2003

None

Tissue

Milk

MRL

40 µg/l

Year of Adoption

2003

Note

None

Muscle

20 µg/kg

2003

None

Tissue

Muscle

MRL

20 µg/kg

Year of Adoption

2003

Note

None

Showing 1 to 5 of 5 entries

Cyhalothrin

Tissue

MRL

Year of Adoption

Note

Fat

400 µg/kg

2005

None

Tissue

Fat

MRL

400 µg/kg

Year of Adoption

2005

Note

None

Kidney

20 µg/kg

2005

None

Tissue

Kidney

MRL

20 µg/kg

Year of Adoption

2005

Note

None

Liver

20 µg/kg

2005

None

Tissue

Liver

MRL

20 µg/kg

Year of Adoption

2005

Note

None

Milk

30 µg/kg

2005

None

Tissue

Milk

MRL

30 µg/kg

Year of Adoption

2005

Note

None

Muscle

20 µg/kg

2005

None

Tissue

Muscle

MRL

20 µg/kg

Year of Adoption

2005

Note

None

Showing 1 to 5 of 5 entries

Danofloxacin

Tissue

MRL

Year of Adoption

Note

Fat

100 µg/kg

2001

None

Tissue

Fat

MRL

100 µg/kg

Year of Adoption

2001

Note

None

Kidney

400 µg/kg

2001

None

Tissue

Kidney

MRL

400 µg/kg

Year of Adoption

2001

Note

None

Liver

400 µg/kg

2001

None

Tissue

Liver

MRL

400 µg/kg

Year of Adoption

2001

Note

None

Muscle

200 µg/kg

2001

None

Tissue

Muscle

MRL

200 µg/kg

Year of Adoption

2001

Note

None

Showing 1 to 4 of 4 entries

Deltamethrin

Tissue

MRL

Year of Adoption

Note

Fat

500 µg/kg

2003

None

Tissue

Fat

MRL

500 µg/kg

Year of Adoption

2003

Note

None

Kidney

50 µg/kg

2003

None

Tissue

Kidney

MRL

50 µg/kg

Year of Adoption

2003

Note

None

Liver

50 µg/kg

2003

None

Tissue

Liver

MRL

50 µg/kg

Year of Adoption

2003

Note

None

Milk

30 µg/kg

2003

None

Tissue

Milk

MRL

30 µg/kg

Year of Adoption

2003

Note

None

Muscle

30 µg/kg

2003

None

Tissue

Muscle

MRL

30 µg/kg

Year of Adoption

2003

Note

None

Showing 1 to 5 of 5 entries

Dexamethasone

Tissue

MRL

Year of Adoption

Note

Kidney

1.0 µg/kg

2009

None

Tissue

Kidney

MRL

1.0 µg/kg

Year of Adoption

2009

Note

None

Liver

2.0 µg/kg

2009

None

Tissue

Liver

MRL

2.0 µg/kg

Year of Adoption

2009

Note

None

Milk

0.3 µg/l

2009

None

Tissue

Milk

MRL

0.3 µg/l

Year of Adoption

2009

Note

None

Muscle

1.0 µg/kg

2009

None

Tissue

Muscle

MRL

1.0 µg/kg

Year of Adoption

2009

Note

None

Showing 1 to 4 of 4 entries

Dihydrostreptomycin/Streptomycin

Tissue

MRL

Year of Adoption

Note

Fat

600 µg/kg

2001

None

Tissue

Fat

MRL

600 µg/kg

Year of Adoption

2001

Note

None

Kidney

1000 µg/kg

2001

None

Tissue

Kidney

MRL

1000 µg/kg

Year of Adoption

2001

Note

None

Liver

600 µg/kg

2001

None

Tissue

Liver

MRL

600 µg/kg

Year of Adoption

2001

Note

None

Milk

200 µg/kg

2003

None

Tissue

Milk

MRL

200 µg/kg

Year of Adoption

2003

Note

None

Muscle

600 µg/kg

2001

None

Tissue

Muscle

MRL

600 µg/kg

Year of Adoption

2001

Note

None

Showing 1 to 5 of 5 entries

Diminazene

Tissue

MRL

Year of Adoption

Note

Kidney

6000 µg/kg

1997

None

Tissue

Kidney

MRL

6000 µg/kg

Year of Adoption

1997

Note

None

Liver

12000 µg/kg

1997

None

Tissue

Liver

MRL

12000 µg/kg

Year of Adoption

1997

Note

None

Milk

150 µg/l

1997

Limit of quantitation of the analytical method.

Tissue

Milk

MRL

150 µg/l

Year of Adoption

1997

Note

Limit of quantitation of the analytical method.

Muscle

500 µg/kg

1997

None

Tissue

Muscle

MRL

500 µg/kg

Year of Adoption

1997

Note

None

Showing 1 to 4 of 4 entries

Doramectin

Tissue

MRL

Year of Adoption

Note

Fat

150 µg/kg

1997

High concentration of residues at the injection site over a 35 day period after subcutaneous or intramuscular administration of the drug at the recommended dose.

Tissue

Fat

MRL

150 µg/kg

Year of Adoption

1997

Note

High concentration of residues at the injection site over a 35 day period after subcutaneous or intramuscular administration of the drug at the recommended dose.

Kidney

30 µg/kg

1997

None

Tissue

Kidney

MRL

30 µg/kg

Year of Adoption

1997

Note

None

Liver

100 µg/kg

1997

None

Tissue

Liver

MRL

100 µg/kg

Year of Adoption

1997

Note

None

Milk

15 µg/kg

2006

Depending on the route and/or time of administration the use of doramectin in dairy cows may result in extended withdrawal periods in milk. This may be addressed in national/regional regulatory programmes.

Tissue

Milk

MRL

15 µg/kg

Year of Adoption

2006

Note

Muscle

10 µg/kg

1997

High concentration of residues at the injection site over a 35 day period after subcutaneous or intramuscular administration of the drug at the recommended dose.

Tissue

Muscle

MRL

10 µg/kg

Year of Adoption

1997

Note

High concentration of residues at the injection site over a 35 day period after subcutaneous or intramuscular administration of the drug at the recommended dose.

Showing 1 to 5 of 5 entries

Eprinomectin

Tissue

MRL

Year of Adoption

Note

Fat

250 µg/kg

2003

None

Tissue

Fat

MRL

250 µg/kg

Year of Adoption

2003

Note

None

Kidney

300 µg/kg

2003

None

Tissue

Kidney

MRL

300 µg/kg

Year of Adoption

2003

Note

None

Liver

2000 µg/kg

2003

None

Tissue

Liver

MRL

2000 µg/kg

Year of Adoption

2003

Note

None

Milk

20 µg/l

2003

None

Tissue

Milk

MRL

20 µg/l

Year of Adoption

2003

Note

None

Muscle

100 µg/kg

2003

None

Tissue

Muscle

MRL

100 µg/kg

Year of Adoption

2003

Note

None

Showing 1 to 5 of 5 entries

Estradiol-17beta

Tissue

MRL

Year of Adoption

Note

Fat

unnecessary -

1995

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Fat

MRL

unnecessary -

Year of Adoption

1995

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Kidney

unnecessary -

1995

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Kidney

MRL

unnecessary -

Year of Adoption

1995

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Liver

unnecessary -

1995

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Liver

MRL

unnecessary -

Year of Adoption

1995

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Muscle

unnecessary -

1995

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Muscle

MRL

unnecessary -

Year of Adoption

1995

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Showing 1 to 4 of 4 entries

Febantel/Fenbendazole/Oxfendazole

Tissue

MRL

Year of Adoption

Note

Fat

100 µg/kg

1999

None

Tissue

Fat

MRL

100 µg/kg

Year of Adoption

1999

Note

None

Kidney

100 µg/kg

1999

None

Tissue

Kidney

MRL

100 µg/kg

Year of Adoption

1999

Note

None

Liver

500 µg/kg

1999

None

Tissue

Liver

MRL

500 µg/kg

Year of Adoption

1999

Note

None

Milk

100 µg/l

1999

None

Tissue

Milk

MRL

100 µg/l

Year of Adoption

1999

Note

None

Muscle

100 µg/kg

1999

None

Tissue

Muscle

MRL

100 µg/kg

Year of Adoption

1999

Note

None

Showing 1 to 5 of 5 entries

Fluazuron

Tissue

MRL

Year of Adoption

Note

Fat

7000 µg/kg

1999

None

Tissue

Fat

MRL

7000 µg/kg

Year of Adoption

1999

Note

None

Kidney

500 µg/kg

1999

None

Tissue

Kidney

MRL

500 µg/kg

Year of Adoption

1999

Note

None

Liver

500 µg/kg

1999

None

Tissue

Liver

MRL

500 µg/kg

Year of Adoption

1999

Note

None

Muscle

200 µg/kg

1999

None

Tissue

Muscle

MRL

200 µg/kg

Year of Adoption

1999

Note

None

Showing 1 to 4 of 4 entries

Flumequine

Tissue

MRL

Year of Adoption

Note

Fat

1000 µg/kg

2005

None

Tissue

Fat

MRL

1000 µg/kg

Year of Adoption

2005

Note

None

Kidney

3000 µg/kg

2005

None

Tissue

Kidney

MRL

3000 µg/kg

Year of Adoption

2005

Note

None

Liver

500 µg/kg

2005

None

Tissue

Liver

MRL

500 µg/kg

Year of Adoption

2005

Note

None

Muscle

500 µg/kg

2005

None

Tissue

Muscle

MRL

500 µg/kg

Year of Adoption

2005

Note

None

Showing 1 to 4 of 4 entries

Gentamicin

Tissue

MRL

Year of Adoption

Note

Fat

100 µg/kg

2001

None

Tissue

Fat

MRL

100 µg/kg

Year of Adoption

2001

Note

None

Kidney

5000 µg/kg

2001

None

Tissue

Kidney

MRL

5000 µg/kg

Year of Adoption

2001

Note

None

Liver

2000 µg/kg

2001

None

Tissue

Liver

MRL

2000 µg/kg

Year of Adoption

2001

Note

None

Milk

200 µg/l

2001

None

Tissue

Milk

MRL

200 µg/l

Year of Adoption

2001

Note

None

Muscle

100 µg/kg

2001

None

Tissue

Muscle

MRL

100 µg/kg

Year of Adoption

2001

Note

None

Showing 1 to 5 of 5 entries

Imidocarb

Tissue

MRL

Year of Adoption

Note

Fat

50 µg/kg

2005

None

Tissue

Fat

MRL

50 µg/kg

Year of Adoption

2005

Note

None

Kidney

2000 µg/kg

2005

None

Tissue

Kidney

MRL

2000 µg/kg

Year of Adoption

2005

Note

None

Liver

1500 µg/kg

2005

None

Tissue

Liver

MRL

1500 µg/kg

Year of Adoption

2005

Note

None

Milk

50 µg/kg

2005

None

Tissue

Milk

MRL

50 µg/kg

Year of Adoption

2005

Note

None

Muscle

300 µg/kg

2005

None

Tissue

Muscle

MRL

300 µg/kg

Year of Adoption

2005

Note

None

Showing 1 to 5 of 5 entries

Isometamidium

Tissue

MRL

Year of Adoption

Note

Fat

100 µg/kg

1995

None

Tissue

Fat

MRL

100 µg/kg

Year of Adoption

1995

Note

None

Kidney

1000 µg/kg

1995

None

Tissue

Kidney

MRL

1000 µg/kg

Year of Adoption

1995

Note

None

Liver

500 µg/kg

1995

None

Tissue

Liver

MRL

500 µg/kg

Year of Adoption

1995

Note

None

Milk

100 µg/l

1995

None

Tissue

Milk

MRL

100 µg/l

Year of Adoption

1995

Note

None

Muscle

100 µg/kg

1995

None

Tissue

Muscle

MRL

100 µg/kg

Year of Adoption

1995

Note

None

Showing 1 to 5 of 5 entries

Ivermectin

Tissue

MRL

Year of Adoption

Note

Fat

400 µg/kg

2017

None

Tissue

Fat

MRL

400 µg/kg

Year of Adoption

2017

Note

None

Kidney

100 µg/kg

2017

None

Tissue

Kidney

MRL

100 µg/kg

Year of Adoption

2017

Note

None

Liver

800 µg/kg

2017

None

Tissue

Liver

MRL

800 µg/kg

Year of Adoption

2017

Note

None

Milk

10 µg/kg

2003

None

Tissue

Milk

MRL

10 µg/kg

Year of Adoption

2003

Note

None

Muscle

30 µg/kg

2017

None

Tissue

Muscle

MRL

30 µg/kg

Year of Adoption

2017

Note

None

Showing 1 to 5 of 5 entries

Levamisole

Tissue

MRL

Year of Adoption

Note

Fat

10 µg/kg

1997

None

Tissue

Fat

MRL

10 µg/kg

Year of Adoption

1997

Note

None

Kidney

10 µg/kg

1997

None

Tissue

Kidney

MRL

10 µg/kg

Year of Adoption

1997

Note

None

Liver

100 µg/kg

1997

None

Tissue

Liver

MRL

100 µg/kg

Year of Adoption

1997

Note

None

Muscle

10 µg/kg

1997

None

Tissue

Muscle

MRL

10 µg/kg

Year of Adoption

1997

Note

None

Showing 1 to 4 of 4 entries

Lincomycin

Tissue

MRL

Year of Adoption

Note

Milk

150 µg/kg

2003

None

Tissue

Milk

MRL

150 µg/kg

Year of Adoption

2003

Note

None

Showing 1 to 1 of 1 entries

Moxidectin

Tissue

MRL

Year of Adoption

Note

Fat

500 µg/kg

1997

None

Tissue

Fat

MRL

500 µg/kg

Year of Adoption

1997

Note

None

Kidney

50 µg/kg

1997

None

Tissue

Kidney

MRL

50 µg/kg

Year of Adoption

1997

Note

None

Liver

100 µg/kg

1997

None

Tissue

Liver

MRL

100 µg/kg

Year of Adoption

1997

Note

None

Muscle

20 µg/kg

1997

Very high concentration and great variation in the level of residues at the injection site in cattle over a 49 day period after dosing.

Tissue

Muscle

MRL

20 µg/kg

Year of Adoption

1997

Note

Very high concentration and great variation in the level of residues at the injection site in cattle over a 49 day period after dosing.

Showing 1 to 4 of 4 entries

Neomycin

Tissue

MRL

Year of Adoption

Note

Fat

500 µg/kg

1999

None

Tissue

Fat

MRL

500 µg/kg

Year of Adoption

1999

Note

None

Kidney

10000 µg/kg

2005

None

Tissue

Kidney

MRL

10000 µg/kg

Year of Adoption

2005

Note

None

Liver

500 µg/kg

2005

None

Tissue

Liver

MRL

500 µg/kg

Year of Adoption

2005

Note

None

Milk

1500 µg/kg

2005

None

Tissue

Milk

MRL

1500 µg/kg

Year of Adoption

2005

Note

None

Muscle

500 µg/kg

1999

None

Tissue

Muscle

MRL

500 µg/kg

Year of Adoption

1999

Note

None

Showing 1 to 5 of 5 entries

Progesterone

Tissue

MRL

Year of Adoption

Note

Fat

unnecessary -

2005

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Fat

MRL

unnecessary -

Year of Adoption

2005

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Kidney

unnecessary -

2005

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Kidney

MRL

unnecessary -

Year of Adoption

2005

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Liver

unnecessary -

2005

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Liver

MRL

unnecessary -

Year of Adoption

2005

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Muscle

unnecessary -

2005

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Muscle

MRL

unnecessary -

Year of Adoption

2005

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Showing 1 to 4 of 4 entries

Spectinomycin

Tissue

MRL

Year of Adoption

Note

Fat

2000 µg/kg

1999

None

Tissue

Fat

MRL

2000 µg/kg

Year of Adoption

1999

Note

None

Kidney

5000 µg/kg

1999

None

Tissue

Kidney

MRL

5000 µg/kg

Year of Adoption

1999

Note

None

Liver

2000 µg/kg

1999

None

Tissue

Liver

MRL

2000 µg/kg

Year of Adoption

1999

Note

None

Milk

200 µg/l

1999

None

Tissue

Milk

MRL

200 µg/l

Year of Adoption

1999

Note

None

Muscle

500 µg/kg

1999

None

Tissue

Muscle

MRL

500 µg/kg

Year of Adoption

1999

Note

None

Showing 1 to 5 of 5 entries

Spiramycin

Tissue

MRL

Year of Adoption

Note

Fat

300 µg/kg

1997

None

Tissue

Fat

MRL

300 µg/kg

Year of Adoption

1997

Note

None

Kidney

300 µg/kg

1997

None

Tissue

Kidney

MRL

300 µg/kg

Year of Adoption

1997

Note

None

Liver

600 µg/kg

1997

None

Tissue

Liver

MRL

600 µg/kg

Year of Adoption

1997

Note

None

Milk

200 µg/l

1997

None

Tissue

Milk

MRL

200 µg/l

Year of Adoption

1997

Note

None

Muscle

200 µg/kg

1997

None

Tissue

Muscle

MRL

200 µg/kg

Year of Adoption

1997

Note

None

Showing 1 to 5 of 5 entries

Sulfadimidine

Tissue

MRL

Year of Adoption

Note

Milk

25 µg/l

1995

None

Tissue

Milk

MRL

25 µg/l

Year of Adoption

1995

Note

None

Showing 1 to 1 of 1 entries

Testosterone

Tissue

MRL

Year of Adoption

Note

Fat

unnecessary -

1995

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Fat

MRL

unnecessary -

Year of Adoption

1995

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Kidney

unnecessary -

1995

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Kidney

MRL

unnecessary -

Year of Adoption

1995

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Liver

unnecessary -

1995

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Liver

MRL

unnecessary -

Year of Adoption

1995

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Muscle

unnecessary -

1995

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Tissue

Muscle

MRL

unnecessary -

Year of Adoption

1995

Note

Residues resulting from the use of this substances as a growth promoter in accordance with good animal husbandry practice are unlikely to pose a hazard to human health.

Showing 1 to 4 of 4 entries

Thiabendazole

Tissue

MRL

Year of Adoption

Note

Fat

100 µg/kg

1995

The MRL also covers residues derived from feed containing the residues resulted from agricultural use.

Tissue

Fat

MRL

100 µg/kg

Year of Adoption

1995

Note

The MRL also covers residues derived from feed containing the residues resulted from agricultural use.

Kidney

100 µg/kg

1995

The MRL also covers residues derived from feed containing the residues resulted from agricultural use.

Tissue

Kidney

MRL

100 µg/kg

Year of Adoption

1995

Note

The MRL also covers residues derived from feed containing the residues resulted from agricultural use.

Liver

100 µg/kg

1995

The MRL also covers residues derived from feed containing the residues resulted from agricultural use.

Tissue

Liver

MRL

100 µg/kg

Year of Adoption

1995

Note

The MRL also covers residues derived from feed containing the residues resulted from agricultural use.

Milk

100 µg/l

1995

The MRL also covers residues derived from feed containing the residues resulted from agricultural use.

Tissue

Milk

MRL

100 µg/l

Year of Adoption

1995

Note

The MRL also covers residues derived from feed containing the residues resulted from agricultural use.

Muscle

100 µg/kg

1995

The MRL also covers residues derived from feed containing the residues resulted from agricultural use.

Tissue

Muscle

MRL

100 µg/kg

Year of Adoption

1995

Note

The MRL also covers residues derived from feed containing the residues resulted from agricultural use.

Showing 1 to 5 of 5 entries

Tilmicosin

Tissue

MRL

Year of Adoption

Note

Fat

100 µg/kg

1999

None

Tissue

Fat

MRL

100 µg/kg

Year of Adoption

1999

Note

None

Kidney

300 µg/kg

1999

None

Tissue

Kidney

MRL

300 µg/kg

Year of Adoption

1999

Note

None

Liver

1000 µg/kg

1999

None

Tissue

Liver

MRL

1000 µg/kg

Year of Adoption

1999

Note

None

Muscle

100 µg/kg

1999

None

Tissue

Muscle

MRL

100 µg/kg

Year of Adoption

1999

Note

None

Showing 1 to 4 of 4 entries

Trenbolone acetate

Tissue

MRL

Year of Adoption

Note

Liver

10 µg/kg

1995

None

Tissue

Liver

MRL

10 µg/kg

Year of Adoption

1995

Note

None

Muscle

2 µg/kg

1995

None

Tissue

Muscle

MRL

2 µg/kg

Year of Adoption

1995

Note

None

Showing 1 to 2 of 2 entries

Trichlorfon (metrifonate)

Tissue

MRL

Year of Adoption

Note

Milk

50 µg/l

2006

None

Tissue

Milk

MRL

50 µg/l

Year of Adoption

2006

Note

None

Showing 1 to 1 of 1 entries

Triclabendazole

Tissue

MRL

Year of Adoption

Note

Fat/Skin

100 µg/kg

2009

None

Tissue

Fat/Skin

MRL

100 µg/kg

Year of Adoption

2009

Note

None

Kidney

400 µg/kg

2009

None

Tissue

Kidney

MRL

400 µg/kg

Year of Adoption

2009

Note

None

Liver

850 µg/kg

2009

None

Tissue

Liver

MRL

850 µg/kg

Year of Adoption

2009

Note

None

Muscle

250 µg/kg

2009

None

Tissue

Muscle

MRL

250 µg/kg

Year of Adoption

2009

Note

None

Showing 1 to 4 of 4 entries

Zeranol

Tissue

MRL

Year of Adoption

Note

Liver

10 µg/kg

1995

None

Tissue

Liver

MRL

10 µg/kg

Year of Adoption

1995

Note

None

Muscle

2 µg/kg

1995

None

Tissue

Muscle

MRL

2 µg/kg

Year of Adoption

1995

Note

None